This is not surprising as Thal and colleagues found the frequency of APOE ε4 carriers in type 1 CAA is 4 times higher than in type 2 CAA in AD and controls, and type 2 CAA has a higher APOE ε2 frequency compared to type 1 CAA [54]. This evidence concerns the gene APOE and Alzheimer disease.